Evolent Health Overview
Evolent Health Target Price
See Evolent Health's analyst price targets ($6.7) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$4.1
Average Target Price
$6.67
62.6% upside
62.6% upside3 analysts in the last 4 months
High: $7 | Low: $6
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-21 | Canaccord Genuity | $7 | 70.7% upside |  |
| 2026-06-30 | Truist Financial | $7 | 70.7% upside | |
| 2026-05-12 | Canaccord Genuity | $6 | 46.3% upside | |
| 2026-02-25 | Truist Financial | $6 | 46.3% upside | |
| 2026-02-25 | BMO CapitalSean Dodge | $3.5 |  14.6% downside | |
| 2026-02-02 | BTIGDavid Larsen | $10 | 143.9% upside | |
| 2025-12-02 | Piper Sandler | $6 | 46.3% upside | |
| 2025-01-16 | UBSKevin Caliendo | $14 | 241.5% upside | |
| 2025-01-15 | Truist FinancialJailendra Singh | $20 | 387.8% upside | |
| 2025-01-14 | RBC CapitalSean Dodge | $17 | 314.6% upside | |
| 2025-01-10 | JMP SecuritiesConstantine Davides | $18 | 339% upside | |
| 2024-11-18 | OppenheimerMohan Naidu | $28 | 582.9% upside | |
| 2024-10-17 | StephensJeff Garro | $38 | 826.8% upside | |
| 2024-08-09 | Truist FinancialJailendra Singh | $33 | 704.9% upside | |
| 2024-06-05 | RBC CapitalSean Dodge | $42 | 924.4% upside | |
| 2024-05-14 | Truist FinancialJailendra Singh | $28 | 582.9% upside | |
| 2024-04-17 | Piper SandlerJessica Tassan | $51 | 1143.9% upside | |
| 2024-03-28 | Canaccord GenuityRichard Close | $44 | 973.2% upside | |
| 2022-08-03 | BTIG | $50 | 1119.5% upside | |
| 2022-05-09 | Canaccord Genuity | $45 | 997.6% upside | |